Hints and tips:
Related Special Reports
...It has also worked on drug development for US pharma company Johnson & Johnson, Danish biotech group Genmab and British biotech Iksuda therapeutics....
...Chief executives at AbbVie, Eli Lilly, and Johnson & Johnson all earned more than Soriot in 2023....
...Johnson & Johnson has struck a deal to buy medical device maker Shockwave Medical for $13.1bn, as the healthcare giant pursues acquisitions to bolster its medical technology arm....
...Johnson & Johnson has struck a deal to buy medical device maker Shockwave Medical for $13.1bn, as the healthcare giant puts cash to work from the spin-off of its consumer health arm to pursue acquisitions...
...The UK government’s flagship “Eat Out to Help Out” restaurant discount scheme in the summer of 2020 was not presented to Boris Johnson as “a gamble”, the former prime minister has told the public inquiry...
...Johnson & Johnson has raised its forecasts for the full year after it beat expectations on earnings and revenue, partly driven by soaring sales of cancer drugs in the US....
...HOLD: Synthomer (SYNT) There are some green shoots starting to emerge, but recovery is an uphill struggle, writes Jennifer Johnson....
...Johnson Matthey: Shares in the London-listed chemicals producer were up 8 per cent after the company said it was selling its medical device components business to Montagu Private Equity for $700mn....
...But Johnson admitted he had heard Professor Chris Whitty, England’s chief medical officer, describe it as “Eat Out to Help Out the Virus” in September 2020....
...Ministers introduced a three-tier system of curbs in England in mid-October, before a national lockdown came into force in November to prevent what Johnson called a “medical and moral disaster” for the NHS...
...HOLD: Bioventix (BVXP) Its products might sound obscure, but they’re prized by medical researchers, writes Jennifer Johnson....
...The inquiry was also shown an email exchange in which former deputy chief medical officer Dame Jenny Harries said discharging Covid patients into care homes would be “entirely clinically appropriate” in...
...And he even explores acquiring a pharmaceuticals company to move cocaine around the world disguised as medical exports but that never gets off the ground. But some of his schemes do work....
...Johnson & Johnson raised its full year profit forecast for 2023 on Thursday after reporting strong sales of cancer drugs and medical devices in the second quarter....
...Some have speculated that Reckitt has been trying to sell Mead Johnson, the infant formula business it acquired for $17bn in 2017....
...The hoarding of for-profit vaccines and other medical technologies in the global north should have been reconsidered. However, just a few years later, Covid-19 swept across the planet....
...In the past year, Novo Nordisk has become Europe’s largest company by market capitalisation, while Eli Lilly overtook Johnson & Johnson as the world’s most valuable pharma company, on the back of high demand...
...Meanwhile, vaccine makers whose stocks were winners of the early pandemic period such as Pfizer, BioNTech, Moderna and Johnson & Johnson have been among the worst-performers in a year when the S&P 500 approached...
...The four pharmaceutical companies that part-funded the project — Amgen, AstraZeneca, GSK and Johnson & Johnson, — received nine months’ exclusive access to the data, which will now be made available to approved...
...Chris Whitty, England’s chief medical officer since 2019, privately characterised Sunak’s programme as “Eat Out to Help Out the Virus”, the inquiry has heard....
...The UK government took too long to impose the first national lockdown as the pandemic unfolded, England’s chief medical officer told the official Covid inquiry on Tuesday....
...Recalling a government planning meeting in February 2020, he said: “The secretary of state for health and social care took the position that in this situation he — rather than, say, the medical profession...
...The inquiry is, in part, a trial of Boris Johnson....
..., England’s chief medical officer, “what they thought”....
...Take Johnson....
International Edition